New York S 4482: Requires practitioners who administer naloxone or another overdose reversal agent to a patient to report the administration of the agent to the prescription monitoring program registry

Status: REFERRED TO HEALTH (as of 2020-01-08)

State: New York · Session: 2019-2020 · Bill: S 4482

Sponsors: HARCKHAM

View New York S 4482 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.